{
    "clinical_study": {
        "@rank": "55300", 
        "arm_group": {
            "arm_group_label": "Acellular Dermal Matrix", 
            "description": "A tailored piece of Acellular Dermal Matrix will be placed between the oral and nasal layers at the time of a Furlow Palatoplasty for repair of a Cleft Palate."
        }, 
        "brief_summary": {
            "textblock": "The goal of the present study is to definitely determine whether the use of acellular dermal\n      matrix (ADM) during primary cleft palate repair decreases the rate of fistula formation.\n      Although individual studies have described promising advantages to its use in cleft palate\n      surgery, no consensus currently exists. Without concrete evidence, one must question the\n      whether the increased cost, time and potential patient risk (human derived tissue) to\n      patients justifies its use in primary cleft palate repair."
        }, 
        "brief_title": "Acellular Dermal Matrix in Primary Furlow Palatoplasty", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cleft Palate", 
        "condition_browse": {
            "mesh_term": "Cleft Palate"
        }, 
        "detailed_description": {
            "textblock": "Observational study composed of a prospective cohort group receiving ADM compared to a\n      retrospective historical cohort group without ADM.\n\n      Objectives of the study:\n\n      Primary objectives:\n\n      The primary objective of this study is to determine whether ADM would lower the incidence of\n      palatal fistula in patients undergoing primary cleft palate repair.\n\n      Secondary objectives:\n\n        1. Incidence of wound dehiscence\n\n        2. Incidence of wound infection\n\n        3. Hospital length of stay"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children diagnosed as having Veau class II to IV cleft palates undergoing Furlow\n             palatoplasty with ADM between the ages of 3 months and 3 years will be included in\n             this study.\n\n        Exclusion Criteria:\n\n          -  Selection will be based on the parent's willingness to allow their child to\n             participate in the study.\n\n          -  Children with diagnosed craniofacial syndromes will be excluded from the study due\n             their higher than usual incidence of palatal fistulas.\n\n          -  Children with known wound healing defects, such as Ehler Danlos syndrome,\n             Pseudoxanthoma Elasticum, will be excluded from the study due to their inherent\n             collagen defects and consequently on the incidence of palatal fistulas.\n\n          -  Children with Veau class I cleft palates and those who will need/needed any surgical\n             technique other then Furlow palatoplasty will be excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "3 Years", 
            "minimum_age": "3 Months", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Children who present to the Montreal Children's Hospital with a cleft palate (Veau II-IV)\n        that undergo surgical repair between the age of 3 months and 3 years."
            }
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867632", 
            "org_study_id": "12-073-PED"
        }, 
        "intervention": {
            "arm_group_label": "Acellular Dermal Matrix", 
            "intervention_name": "Acellular Dermal Matrix", 
            "intervention_type": "Device", 
            "other_name": "DermaMatrix"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Furlow Palatoplasty", 
            "Acellular Dermal Matrix"
        ], 
        "lastchanged_date": "May 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H3H1P3"
                }, 
                "name": "Montreal Children's Hospital"
            }, 
            "investigator": {
                "last_name": "Mirko S. Gilardino, MD MSc FRCSC", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Does Acellular Dermal Matrix Reduce Fistula Rate in Primary Furlow Palatoplasty", 
        "overall_contact": {
            "last_name": "Mirko S Gilardino, MD", 
            "phone": "514.934.1934", 
            "phone_ext": "23472"
        }, 
        "overall_official": {
            "affiliation": "Montreal Children's Hospital of the MUHC", 
            "last_name": "Mirko  , S Gilardino, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Fistula formation", 
            "safety_issue": "No", 
            "time_frame": "Within 1 year of surgery"
        }, 
        "reference": {
            "PMID": "22743882", 
            "citation": "Aldekhayel SA, Sinno H, Gilardino MS. Acellular dermal matrix in cleft palate repair: an evidence-based review. Plast Reconstr Surg. 2012 Jul;130(1):177-82. doi: 10.1097/PRS.0b013e318254b2dc. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867632"
        }, 
        "responsible_party": {
            "investigator_affiliation": "McGill University Health Center", 
            "investigator_full_name": "Mirko S. Gilardino", 
            "investigator_title": "Director, Plastic Surgery Residency Program, Assistant Professor of Surgery", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Wound infection", 
            "safety_issue": "No", 
            "time_frame": "Within 1 year of surgery"
        }, 
        "source": "McGill University Health Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mirko S. Gilardino", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}